Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Bertolini Mark T	2. Issuer Name and Ticker or Trading Symbol AETNA INC /PA/ [ AET ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman and CEO
(Last) (First) (Middle) 151 FARMINGTON AVENUE	3. Date of Earliest Transaction (MM/DD/YYYY) 11/28/2018
(Street) HARTFORD, CT 06156 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/28/2018		M		72500 ⁽¹⁾	A	$0	124037	D
Common Stock	11/28/2018		M		32331 ⁽²⁾	A	$0	156368	D
Common Stock	11/28/2018		M		8893 ⁽³⁾	A	$0	165261	D
Common Stock	11/28/2018		M		13220 ⁽⁴⁾	A	$0	178481	D
Common Stock	11/28/2018		M		17572 ⁽⁵⁾	A	$0	196053	D
Common Stock	11/28/2018		M		76044 ⁽⁵⁾	A	$0	272097	D
Common Stock	11/28/2018		F		102990	D	$209.01 ⁽⁶⁾	169107	D
Common Stock	11/28/2018		D		169107	D	⁽⁷⁾	0	D
Common Stock	11/28/2018		D		119447	D	⁽⁷⁾	0	I	By CLAT ⁽⁸⁾
Common Stock	11/28/2018		D		107098 ⁽⁹⁾	D	⁽⁷⁾	0	I	By 2017 GRAT ⁽¹⁰⁾
Common Stock	11/28/2018		D		107576	D	⁽⁷⁾	0	I	By 2017 GRAT II ⁽¹¹⁾
Common Stock	11/28/2018		D		259969 ⁽¹²⁾	D	⁽⁷⁾	0	I	By 2018 GRAT ⁽¹³⁾
Common Stock	11/28/2018		D		134649 ⁽¹⁴⁾	D	⁽⁷⁾	0	I	By 2016 Trust ⁽¹⁵⁾
Common Stock	11/28/2018		D		14961 ⁽¹⁶⁾	D	⁽⁷⁾	0	I	By 2018 Trust ⁽¹⁷⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽³⁾	11/28/2018		M			8893	⁽³⁾	⁽³⁾	Common Stock	8893	$0 ⁽³⁾	0	D
Restricted Stock Units	⁽⁴⁾	11/28/2018		M			13220	⁽⁴⁾	⁽⁴⁾	Common Stock	13220	$0 ⁽⁴⁾	0	D
Restricted Stock Units	⁽⁵⁾	11/28/2018		M			17572	⁽⁵⁾	⁽⁵⁾	Common Stock	17572	$0 ⁽⁵⁾	0	D
Restricted Stock Units	⁽⁵⁾	11/28/2018		M			76044	⁽⁵⁾	⁽⁵⁾	Common Stock	76044	$0 ⁽⁵⁾	0	D
Stock Appreciation Rights	$32.11	11/28/2018		D			299751	⁽¹⁸⁾	⁽¹⁸⁾	Common Stock	299751	⁽¹⁸⁾	0	D
Stock Appreciation Right	$64.25	11/28/2018		D			500000	⁽¹⁹⁾	⁽¹⁹⁾	Common Stock	500000	⁽¹⁹⁾	0	D
Stock Appreciation Rights	$72.26	11/28/2018		D			304626	⁽²⁰⁾	⁽²⁰⁾	Common Stock	304626	⁽²⁰⁾	0	D
Stock Appreciation Rights	$100.50	11/28/2018		D			253480	⁽²¹⁾	⁽²¹⁾	Common Stock	253480	⁽²¹⁾	0	D
Stock Appreciation Rights	$103.45	11/28/2018		D			253242	⁽²²⁾	⁽²²⁾	Common Stock	253242	⁽²²⁾	0	D
Stock Appreciation Rights	$125.27	11/28/2018		D			260037	⁽²³⁾	⁽²³⁾	Common Stock	260037	⁽²³⁾	0	D
Deferred Stock Units	⁽²⁴⁾	11/28/2018		D			74140.1044	⁽²⁴⁾	⁽²⁴⁾	Common Stock	74140.1044	⁽²⁴⁾	0	D

Explanation of Responses:
(1)	Vesting of performance stock units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on February 19, 2016.
(2)	Vesting of PSUs granted under the Plan on February 17, 2017.
(3)	Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016.
(4)	Vesting of previously reported RSUs granted under the Plan on February 17, 2017.
(5)	Vesting of previously reported RSUs granted under the Plan on March 2, 2018.
(6)	Represents tax withholding on accelerated vesting of PSUs and RSUs granted under the Plan.
(7)	Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
(8)	Represents shares held in Charitable Lead Annuity Trust ("CLAT") for which Reporting Person is the investment advisor.
(9)	On August 27, 2018, 51,537 shares were voluntarily transferred from 2017 Grantor Retained Annuity Trust ("GRAT") to the Reporting Person's sole account.
(10)	Represents shares held by 2017 GRAT for which Reporting Person is sole trustee.
(11)	Represents shares held by 2017 GRAT II for which Reporting Person is sole trustee.
(12)	On July 23, 2018, 145,826 shares were distributed to the Reporting Person's sole account to satisfy 2016 GRAT annuity obligation. On July 31, 2018, 259,969 shares were voluntarily transferred from Reporting Person's sole account to 2018 GRAT.
(13)	Represents shares held by 2018 GRAT for which Reporting Person is sole trustee
(14)	On October 24, 2018, 134,649 shares were transferred from 2016 GRAT to 2016 Trust.
(15)	Represents shares held by a 2016 Trust for which Reporting Person is the investment advisor.
(16)	On October 24, 2018, 14,961 shares were transferred from 2016 GRAT to 2018 Trust.
(17)	Represents shares held by a 2018 Trust for which Reporting Person is the investment advisor.
(18)	Represents Stock Appreciation Rights ("SARs") granted under the Plan on February 13, 2009. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount (the "SAR Amount") in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price.
(19)	Represents SARs granted under the Plan on August 5, 2013. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
(20)	Represents SARs granted under the Plan on March 3, 2014. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
(21)	Represents SARs granted under the Plan on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
(22)	Represents SARs granted under the Plan on February 19, 2016. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
(23)	Represents SARs granted under the Plan on February 17, 2017. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
(24)	Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Bertolini Mark T 151 FARMINGTON AVENUE HARTFORD, CT 06156	X		Chairman and CEO

Signatures
Mark T. Bertolini by Adam F. McAnaney, Attorney-in-Fact		11/28/2018
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.